.Sanofi has brought in a late entrance to the radioligand party, paying out 100 million europeans ($...
.After F2G's 1st effort to get a new lesson of antifungal to market was actually wrecked due to the ...
.Moderna has pledged to reduce R&D spending through $1.1 billion by 2027. The choice to shrink th...
.Merely four months after Sanofi bet $80 million in upfront cash money on Key Rehabs' losmapimod, th...
.Cancer cells firm Oncternal Therapeutics is actually folding all its clinical tests and also giving...
.Roche is holding out hopes that its injectable obesity possibility might inevitably display 25% eff...
.Novo Nordisk has actually raised the top on a phase 1 trial of its own oral amylin and GLP-1 recept...
.Simply a handful of short weeks after gaining an FDA Fast Track tag for its investigational BTK deg...
.Not long after a positive data decline for Eli Lilly's efsitora alfa, the Indianapolis-based provid...
.BridgeBio Pharma is slashing its gene therapy finances and drawing back coming from the technique a...